Boundless Bio, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Zachary Hornby, with a market cap of $25.5M.
Common questions about Boundless Bio, Inc.
Boundless Bio, Inc. is scheduled to report earnings for Q1 2026 on May 8, 2026.
Boundless Bio, Inc. has approximately 72 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.